We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.84B
AUM Growth
-$136M
(-4.5%)
Cap. Flow
-$158M
Cap. Flow
% of AUM
-5.56%
Top 10 Holdings %
Top 10 Hldgs %
32.15%
Holding
473
New
70
Increased
58
Reduced
178
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Burlington
BURL
|
+$39.8M |
| 2 |
L3Harris
LHX
|
+$36.3M |
| 3 |
Amgen
AMGN
|
+$32M |
| 4 |
Delta Air Lines
DAL
|
+$27M |
| 5 |
Ciena
CIEN
|
+$26.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TripAdvisor
TRIP
|
+$48M |
| 2 |
Norfolk Southern
NSC
|
+$32.6M |
| 3 |
Adobe
ADBE
|
+$32.3M |
| 4 |
Advance Auto Parts
AAP
|
+$32.1M |
| 5 |
NetApp
NTAP
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.08% |
| 2 | Healthcare | 13.95% |
| 3 | Consumer Discretionary | 12.73% |
| 4 | Communication Services | 11.1% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Iovance Biotherapeutics
IOVA
$2.9B
| $76K | ﹤0.01% |
+4,190
| New | +$92.7K |
|
252
PTC Therapeutics
PTCT
$6.23B
| $74K | ﹤0.01% |
2,200
+740
| +51% | +$32.2K |
|
|
MRTX
253
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $74K | ﹤0.01% |
+950
| New | +$89.2K |
|
|
IMMU
254
DELISTED
Immunomedics Inc
IMMU
| $74K | ﹤0.01% |
5,560
+1,690
| +44% | +$24.8K |
|
255
Natera
NTRA
$45.9B
| $72K | ﹤0.01% |
+2,200
| New | +$65K |
|
256
Silicom
SILC
$240M
| $72K | ﹤0.01% |
+2,270
| New | +$71K |
|
|
ICPT
257
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $70K | ﹤0.01% |
1,050
+420
| +67% | +$28.2K |
|
258
JPMorgan Chase
JPM
$956B
| $69K | ﹤0.01% |
584
-9,896
| -94% | -$1.12M |
|
259
SunCoke Energy
SXC
$799M
| $67K | ﹤0.01% |
11,957
| – | – |
|
|
NVTA
260
DELISTED
Invitae Corporation
NVTA
| $67K | ﹤0.01% |
+3,460
| New | +$81.6K |
|
|
ARNA
261
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $67K | ﹤0.01% |
1,470
+300
| +26% | +$16.9K |
|
|
FOLD
262
DELISTED
Amicus Therapeutics
FOLD
| $66K | ﹤0.01% |
8,280
+3,320
| +67% | +$36K |
|
263
Quanex
NX
$967M
| $66K | ﹤0.01% |
3,650
| – | – |
|
|
RDUS
264
DELISTED
Radius Recycling
RDUS
| $64K | ﹤0.01% |
3,120
| – | – |
|
|
RDS.B
265
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $64K | ﹤0.01% |
1,062
-241
| -18% | -$14.4K |
|
|
GHDX
266
DELISTED
Genomic Health, Inc.
GHDX
| $64K | ﹤0.01% |
+950
| New | +$65.2K |
|
|
SHOE
267
Shoe Station Group
SHOE
$437M
| $63K | ﹤0.01% |
3,860
| – | – |
|
268
TotalEnergies
TTE
$195B
| $63K | ﹤0.01% |
1,206
-644
| -35% | -$33.4K |
|
269
Wells Fargo
WFC
$265B
| $61K | ﹤0.01% |
1,200
-90
| -7% | -$4.24K |
|
270
PetMed Express
PETS
$42.1M
| $60K | ﹤0.01% |
3,310
| – | – |
|
271
Xencor
XNCR
$1.6B
| $60K | ﹤0.01% |
+1,780
| New | +$71.1K |
|
272
Citigroup
C
$227B
| $59K | ﹤0.01% |
850
-80
| -9% | -$5.44K |
|
273
Insmed
INSM
$29.4B
| $56K | ﹤0.01% |
3,150
+840
| +36% | +$16.2K |
|
|
XLRN
274
DELISTED
Acceleron Pharma
XLRN
| $54K | ﹤0.01% |
1,370
+530
| +63% | +$23K |
|
275
Heron Therapeutics
HRTX
$63.4M
| $53K | ﹤0.01% |
2,840
+530
| +23% | +$9.76K |
|
Similar funds
M
GWM
QT
SCM
TW
KFA
SG
FFA
Smith Group Asset Management's Q3 2019 Portfolio in Review
As of Q3 2019, Smith Group Asset Management held 473 positions worth $2.84B, down 4.5% from $2.98B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Smith Group Asset Management withdrew a net $158M in Q3 2019, closing 96 positions and reducing 178 holdings. Its most notable exit was TripAdvisor, an estimated $48M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Smith Group Asset Management opened a new position in Burlington worth $43.2M.
- Smith Group Asset Management's largest Q3 2019 buy was Burlington: 216,261 shares worth $43.2M.
- Smith Group Asset Management added most to Emcor in Q3 2019, an estimated $24M increase.
- Smith Group Asset Management's biggest Q3 2019 reduction was Adobe, cutting an estimated $32.3M.
- Smith Group Asset Management fully exited TripAdvisor in Q3 2019, selling an estimated $48M.
- Smith Group Asset Management's ten largest holdings make up 32% of its $2.84B portfolio in Q3 2019.
- Smith Group Asset Management opened 70 new positions and closed 96 in Q3 2019.
- Smith Group Asset Management's portfolio value fell 4.5% quarter-over-quarter to $2.84B.
Based on Smith Group Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.